PODD: Partnerships in Drug Delivery Agenda 2026 Page 2

Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

Beate Bittner, PhD, Head Product Optimization, Roche

Showing Events in 1 Track from 08:20am to 09:10am

Morning General Session

8:20AM - 8:50AM

Payer Perspectives on Drug Delivery

Mark Simon, MBA, Strategic Advisor, Sun Pharmaceuticals Industries, Ltd.

Michael Sherman, MD, MBA, MS, Principal, Sherman Healthcare Solutions, LLC

Lambert van der Walde, MBA, SVP & Executive Director, Center for Health Care Research, UnitedHealth Group

8:50AM - 9:10AM

Drug Delivery Pipeline & Technologies, a Year in Review

Kurt Sedo, Executive Editor, PharmaCircle

Showing Events in 1 Track from 09:10am to 09:35am

Patient Keynote

9:10AM - 9:35AM

Patient Keynote: How a CRISPR-Based Therapy Changed Jimi Olaghere’s Life with SCD

Jimi Olaghere, Patient Advocate, Lived-Experience Expert

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

Showing Events in 1 Track from 09:35am to 09:50am

Morning General Session

9:35AM - 9:50AM

Pushing the Limits: What It Will Take to Inject More

Alex Lyness, PhD, Head of Applied Research & Innovation Strategy, SHL Medical

Showing Events in 2 Tracks from 09:50am to 10:45am

PODD Networking Break

9:50AM - 10:45AM

PODD Networking Break

Graciously hosted by:

Partnering Meetings

9:50AM - 10:45AM

Partnering Meetings

Sponsored by:

Showing Events in 1 Track from 10:45am to 12:00pm

Morning General Session Continued

10:45AM - 11:05AM

Zeitgeist Presentation: Endogenous Targeted Delivery Strategies to Advance Nucleic Acid Therapeutics

Mansoor Amiji, PhD, University Distinguished Professor, Northeastern University

11:05AM - 11:25AM

Enabling a Breakthrough in Ophthalmology: A Case Study in Collaboration between a Biotech and Device Manufacturer on a Novel Drug Delivery System

Mark DeStefano, Director of Global Technology Innovation, CPD R&D, Teva Pharmaceuticals

Ashwin Agarwal, MBA, CFO, Azura Ophthalmics

John Merhige, CCO, Credence MedSystems

11:25AM - 11:45AM

Dealmaking Fireside Discussion: Bringing Drug Delivery to the Front

Michael Cucolo, MS, Executive Director, Business Development Transactions, Bristol Myers Squibb

Anand Subramony, PhD, Vice President, Drug Delivery, Device, Connected Solutions & Innovation, Eli Lilly and Company

11:45AM - 12:00PM

The Win-Win-Win Partnership Model: Accelerating Combination Product Success for Emerging Biotech

Ning Yu, PhD, MBA, Vice President, Device and Combination Product, Astria Therapeutics

Lilli Zakarija, MBA, President / Co-Founder, EdgeOne Medical

Showing Events in 1 Track from 12:00pm to 12:45pm

PODD Annual Soapbox Presentations

12:00PM - 12:45PM

PODD Annual Soapbox Presentations, Hosted by Pfizer

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical R&D, Pfizer

Showing Events in 1 Track from 12:45pm to 01:55pm

Luncheon & Partnering Meetings

12:45PM - 1:55PM

Luncheon & Partnering Meetings

Showing Events in 1 Track from 01:55pm to 05:05pm

Four Afternoon Track Choices

1:55PM - 5:05PM

Four Afternoon Track Choices

Showing 3 of 4 Tracks

from 02:00pm to 03:15pm

Novel Formulations

America Ballroom North

Chaired by:

Liping Zhou, PhD, Senior Director, Advanced Drug Delivery, AstraZeneca

Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles

Sanyogitta Puri, PhD, Sr Director, RNA & Gene Therapies - Non-Viral Delivery, Novo Nordisk

Vinu Krishnan, PhD, Principal Research Scientist, CMC Formulation Development & Drug Delivery, AbbVie

Ruchi Shah, PhD, Head US Drug Product, Vaccines Technical R&D, GSK

Anand Subramony, PhD, Vice President, Drug Delivery, Device, Connected Solutions & Innovation, Eli Lilly and Company

Kanika Suri, PhD, Scientist, Drug Product Development, CMC, Takeda Pharmaceuticals

LNP Delivery to Create In Vivo CAR-Monocytes Leads to Complete Depletion of B-Cells in NHPs

Shawn Davis, PhD, CEO, Liberate Bio

Novel Approaches to Achieve Precision Tissue Targeting for Nucleic Acid Therapeutics

Drew Applefield, PhD, Former Director of Search & Evaluation, Platform Technologies, Sanofi

Allison Dane, PhD, Senior Director, AskBio

Ketaki Deshmukh, PhD, Sr. Scientist, Non Viral Delivery, Novo Nordisk

Subhadeep Dutta, PhD, Senior Scientist; Discovery Pharmaceutical Sciences, Merck Research Laboratories

Manmohan Singh, PhD, CTO, Beam Therapeutics

Novel Delivery Modalities

America Ballroom Center

Chaired by:

Lipa Shah, PhD, Director Science and Technology, Drug Development/Pharmaceutical Development, Novartis

Physical and Formulation Approaches for Brain Delivery

Hicham Majd, PhD, Global Device and Packaging Innovation Lead, Novartis

Peter Åhnblad, MD, Co-inventor, Co-Founder of HOGNE AB, HOGNE AB

Karla Sanchez, PhD, CNS Drug Delivery Lead, Cambridge Design Partnership

Mansuo Shannon, PhD, CSO, AskBio/Bayer

One Device, 10-Year Life. A New Era in Drug Delivery

Ashley Hawson, SVP Innovation & Operations, Cambridge Consultants

Elizabeth Proos, Vice President, Product Development, Daré Bioscience

New Approaches for Expanding Transdermal Delivery Opportunities

Tycho Speaker, PhD, Sr Principal Research Scientist, Combination Product Development and Drug Delivery, AbbVie

Rikhav Gala, PhD, Group Lead Sr Principal Scientist, Pfizer

Jatin Sood, PhD, Group Leader – Formulation R&D, ARx LLC

Konstantinos Tzortzakis, CBO, Anodyne Nanotech

Combination Devices

America Ballroom South

Chaired by:

Bryan Dillon, External Manufacturing Operations Lead, Devices, UCB

Platform Approaches to Streamline Combination Product Development

Lindsey Crawford, PhD, Senior Principal Scientist, Pfizer

Bradley Gould, MEng, Director, Device and Combination Product Development, AbbVie

Shirish Ingawale, PhD, Director, Device and Combination Product Development, Takeda

Tim Quigg, Development Director, Crux Product Design

Monica Swinney, PhD, Senior Director, New Product Planning & Drug Delivery Innovation, Gilead Sciences

Combination Products & Platforms for 2030: Leveraging Today’s ‘Best-In-Class’ Device Development Methodologies to Engineer Tomorrow’s Blockbuster Devices

Tim Quigg, Development Director, Crux Product Design

Establishing a Regulatory Framework for Global Combination Device Development

E Guan, PhD, Head of Injection Systems, Takeda

Jonathan Amaya-Hodges, Consulting Director, Suttons Creek, a BlueRidge Life Sciences company

Karen Lowitz, MS, MBA, Associate Director, Regulatory, CMC Devices & Combination Products, Biogen

Novel Drug Delivery and Device Technologies

Independence

Chaired by:

Roger Liu, MEng, MBA, Director, Combination Product Development, AbbVie

The Shift from IV to SC Delivery: Patient and Provider Perspectives

Charles Theuer, MD, PhD, CMO, Halozyme, Inc.

Cathleen Bergin, MSN, ANP, Head of US Field Clinical Educator Team, argenx

Todd Kennedy, Patient and Research Advocate, Lived-Experience Expert

POZ™ + enFuse®: Combining Novel Drug and Device Platforms to Provide a Leap Forward in Patient-Centered Care

Matt Huddleston, CCO, Enable Injections

Randall Moreadith, MD, PhD, CDO, Serina Therapeutics

Advances and Opportunities in Dual Chamber Injectables

Joyce Zhao, PhD, Director, Combination Product Device Development, Takeda Pharmaceuticals

Brent Buchine, PhD, CBO, Windgap Medical, Inc.

David DeSalvo, VP, Combination Product Development, Kindeva

Dan Groszmann, PhD, Director of Engineering, Amgen

Courtney Nicholas Sutton, Head of Portfolio Strategy, SHL Medical

Showing Events in 1 Track from 03:15pm to 03:30pm

15-Minute Break

3:15PM - 3:30PM

15-Minute Break

Showing 3 of 4 Tracks

from 03:35pm to 05:05pm

Novel Formulations

America Ballroom North

Chaired by:

Ana Gomes dos Santos, PhD, Director of Pharm Sci External Evaluations, AstraZeneca

Advances in Payload Delivery and Drug Conjugation

Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, Novartis

Mandana Borna, PhD, Head of Oligonucleotide Drug Product Development, Biogen

Suman Luthra, PhD, Director | Discovery Pharmaceutical Sciences, Merck

Benjamin Smith, PhD, Senior Director, Protein Science and Bioconjugation, Voyager Therapeutics

Stefan Yohe, PhD, Associate Research Fellow, Pfizer

Drug Delivery in the Golden Age of Peptides and Biologics: Novel Formulation Approaches for Oral Delivery

Sarah Tao, PhD, Head of Search and Evaluation, Technology Platforms, Sanofi

Saadyah Averick, PhD, Senior Director Oral Delivery, Imagine Pharma

Stephen Buckley, PhD, VP, Advanced Drug Delivery, Novo Nordisk

Riet Dams, PhD, VP, Global Head Pharmaceutical Product Development & Supply, J&J Innovative Medicine

Thomas von Erlach, PhD, Chief Scientific Officer, Vivtex Corporation

Accomplishing Sustained Release and Long Acting Delivery

Tyler Novak, PhD, Director of Drug Delivery Strategy & Innovation, Gilead Sciences

Christine Allen, PhD, CEO and Co-founder, Intrepid Labs Inc.

Seth Forster, PhD, Associate Principal Scientist, Merck

Shrenik Mehta, PhD, Senior Principal Scientist, Pharmaceutical Development – Drug Delivery, Genentech

Puneet Tyagi, PhD, Associate Director, AstraZeneca

Novel Delivery Modalities

America Ballroom Center

Chaired by:

Advait Badkar, PhD, Executive Director - Drug Product Design and Development & Head of Nanoparticle Development, Pfizer

Enabling At-Home Delivery of Vaccines

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical R&D, Pfizer

Ana Cadete Pires, PharmD, PhD, CMC Project Leader, mRNA Vaccines, Early Programs, Sanofi

Tom Lake, CBO, Vaxxas

Duncan Paterson, CEng, MBA, Sr Director, Device Development, AstraZeneca

New Progress in Ophthalmic Delivery

Shankar Swaminathan, PhD, Team Lead, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Tim Carroll, MS, MBA, Delivery Strategy & Surgeon Engagement, Genentech

Nathan Lockwood, PhD, Director of Science and Technology, ProMed Pharma

Ruchi Thakkar, PhD, Senior Scientist, Bristol Myers Squibb

Respiratory Devices and Inhaled Biologics

Dan Deaton, MBA, Executive Director Device Development and Innovation, AstraZeneca

Charles Potter, PhD, Project Leader, Chiesi

Mireia Puig-Sellart, PharmD, PhD, Manager, Pharmaceutical Development, Phillips Medisize

Philippe Rogueda, PhD, FRSC, CChem, CSci, CBO, Merxin Ltd

Combination Devices

America Ballroom South

Chaired by:

Theresa Scheuble, Head, Enterprise Design & Innovation, Johnson and Johnson

Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success

Kinsuk Shah, M.Sc and MBA, SR AD, Combination Product Steward, Boehringer Ingelheim

Saran Baskaran, BSE, MEng, Associate Director, R&D Combination Products, AstraZeneca

Ana Rusetski, MSc, Sr Manager, Device and Combination Product Development, Astria Therapeutics

Ryan Swanson, PhD, Director of Process Development, Lifecore Injectables CDMO

Ensuring Sustainability Throughout Drug and Device Development

Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals

Patrick Anquetil, PhD, MBA, CEO, Portal Instruments

Andrea Casazza, R&D Global Head of Technical Development, Chiesi

Charlie Dean, Head of Sustainable Medical Technology, Cambridge Consultants

Smrithi Padmakumar, PhD, Associate Principal Scientist, Merck Research Laboratories

Justin Schroeder, MBA, Global VP of Technical Sales, PCI Pharma Services

Utilizing AI to Facilitate Combination Product Development

Theresa Scheuble, Head, Enterprise Design & Innovation, Johnson and Johnson

Fady Ibrahim, PhD, Head of Drug Product Development and Biopharmaceutics, Sanofi

Ameya Phadke, PhD, Sr Director, Non Pharma Solutions, Chiesi

Novel Drug Delivery and Device Technologies

Independence

Chaired by:

Alasdair Young, B.Eng M.Phil, Senior Director - Device Engineering, Gilead Sciences

Using Digital Technologies to Enhance Patient Experience and Better Manage Supply Chain

Ravi Kaushik, VP, Global Head of Device & Digital Innovation & Product Strategy PDT, Takeda

Rebecca Ford, PMP, VP, Strategic Development, Product Design & Engineering, Veranex

Junwei Li, PhD, Innovation Manager, Novo Nordisk

Challenges and Opportunities in Delivering Hyperconcentrated Formulations

Stephanie Reed, PhD, Director, Early Stage Formulation, Biopharmaceutical Development, AstraZeneca

Deep Bhattacharya, PhD, Principal Scientist, Pfizer

Ryan Doxey, Director, Technical Services, Kymanox

Sergie Letser, Deputy CCO and SVP Business Development USA, Nanoform

Novel Approaches to Deliver Large Volume Therapies

Ravi Kaushik, VP, Global Head of Device & Digital Innovation & Product Strategy PDT, Takeda